Influence of δ-opioid receptors in the behavioral effects of nicotine

Neuropsychopharmacology

Volumn 37, Issue 10, 2012, Pages 2332-2344

  Berrendero, Fernando ^a   Plaza Zabala, Ainhoa ^a   Galeote, Lola ^a   Flores, África ^a   Bura, S Andreea ^a   Kieffer, Brigitte L ^b   Maldonado, Rafael ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

dependence; knockout; microdialysis; reward; self administration; tolerance

Indexed keywords

DELTA OPIATE RECEPTOR; DOPAMINE; MECAMYLAMINE; NALTRINDOLE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; GENOTYPE; IN VIVO STUDY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; NOCICEPTION; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; SPINAL CORD; WILD TYPE; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE; MALE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; NOCICEPTION; RECEPTORS, OPIOID, DELTA; REWARD;

EID: 84865267011     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.88     Document Type: Article

References (60)

1. Balerio GN, Aso E, Berrendero F, Murtra P, Maldonado R (2004). Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur J Neurosci 20: 2737-2748. (Pubitemid 39573789)
2. Balerio GN, Aso E, Maldonado R (2005). Involvement of the opioid system in the effects induced by nicotine on anxiety-like behavior in mice. Psychopharmacology (Berl) 181: 260-269. (Pubitemid 41492196)
3. Berrendero F, Kieffer BL, Maldonado R (2002). Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 22: 10935-10940. (Pubitemid 36005169)
4. Berrendero F, Mendizabal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A et al (2005). Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 25: 1103-1112. (Pubitemid 40268951)
5. Berrendero F, Robledo P, Trigo JM, Martín-García E, Maldonado R (2010). Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev 35: 220-231.
6. Brüning CA, Prigol M, Roehrs JA, Zeni G, Nogueira CW (2010). Evidence for the involvement of m-opioid and d-opioid receptors in the antinociceptive effect caused by oral administration of m-trifluoromethyl- diphenyl diselenide in mice. Behav Pharmacol 21: 621-626.
7. Campbell VC, Taylor RE, Tizabi Y (2006). Antinociceptive effects of alcohol and nicotine: involvement of the opioid system. Brain Res 1097: 71-77. (Pubitemid 44043109)
8. Campbell VC, Taylor RE, Tizabi Y (2007). Effects of selective opioid receptor antagonists on alcohol-induced and nicotineinduced antinociception. Alcohol Clin Exp Res 31: 1435-1440. (Pubitemid 47063125)
9. Castañé A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O (2002). Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 43: 857-867. (Pubitemid 35221396)
10. Ciccocioppo R, Martin-Fardon R, Weiss F (2002). Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27: 391-399. (Pubitemid 35256145)
11. Dani JA, Balfour DJ (2011). Historical and current perspective on tobacco use and nicotine addiction. Trends Neurosci 34: 383-392.
12. de Vries J, Babovic-Vuksanovic D, Elmer G, Shippenberg TS (1995). Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine. Psychopharmacology (Berl) 120: 442-448.
13. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278.
14. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F et al (2000). Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25: 195-200. (Pubitemid 30394992)
15. Galeote L, Kieffer BL, Maldonado R, Berrendero F (2006). Muopioid receptors are involved in the tolerance to nicotine antinociception. J Neurochem 97: 416-423.
16. Galeote L, Maldonado R, Berrendero F (2008). Involvement of kappa/dynorphin system in the development of tolerance to nicotine-induced antinociception. J Neurochem 105: 1358-1368. (Pubitemid 351590804)
17. Galeote L, Berrendero F, Bura SA, Zimmer A, Maldonado R (2009). Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice. Int J Neuropsychopharmacol 12: 615-625.
18. Gibaldi M, Perrier D (1975). The trapezoid rule. In: Gibaldi M, Perier D (eds), pp. Pharmacokinetics. Marcel Dekker: New York. pp. 293-296.
19. Göktalay G, Cavun S, Levendusky MC, Hamilton JR, Millington WR (2006). Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. Eur J Pharmacol 530: 95-102. (Pubitemid 43037129)
20. Goody RJ, Oakley SM, Filliol D, Kieffer BL, Kitchen I (2002). Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice. Brain Res 945: 9-19. (Pubitemid 34756571)
21. Hadjiconstantinou M, Neff NH (2011). Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology 60: 1209-1220.
22. Hipólito L, Sánchez-Catalán MJ, Zanolini I, Polache A, Granero L (2008). Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens. Neuropharmacology 55: 183-189.
23. Houdi AA, Dasgupta R, Kindy MS (1998). Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res 799: 257-263. (Pubitemid 28351255)
24. Ise Y, Narita M, Nagase H, Suzuki T (2000). Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Psychopharmacology (Berl) 151: 49-54. (Pubitemid 30639839)
25. Ise Y, Narita M, Nagase H, Suzuki T (2002). Modulation of kappaopioidergic systems on mecamylamine-precipitated nicotinewithdrawal aversion in rats. Neurosci Lett 323: 164-166. (Pubitemid 34310265)
26. Ismayilova N, Shoaib M (2010). Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats. Psychopharmacology (Berl) 210: 211-220.
27. Isola R, Zhang H, Duchemin AM, Tejwani GA, Neff NH, Hadjiconstantinou M (2002). Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse. Neurosci Lett 325: 67-71. (Pubitemid 34521980)
28. Kiguchi N, Maeda T, Tsuruga M, Yamamoto A, Yamamoto C, Ozaki M et al (2008). Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice. Brain Res 1189: 70-77. (Pubitemid 351842550)
29. King A, de Wit H, Riley RC, Cao D, Niaura R, Hatsukami D (2006). Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob Res 8: 671-682. (Pubitemid 44480416)
30. Kitchen I, Slowe SJ, Matthes HW, Kieffer BL (1997). Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res 778: 73-88. (Pubitemid 28039890)
31. Kotlinska JH, Gibula-Bruzda E, Pachuta A, Kunce D, Witkowska E, Chung NN et al (2010). Influence of new deltorphin analogues on reinstatement of cocaine-induced conditioned place preference in rats. Behav Pharmacol 21: 638-648.
32. Le Merrer J, Plaza-Zabala A, Del Boca C, Matifas A, Maldonado R, Kieffer BL (2011). Deletion of the δ opioid receptor gene impairs place conditioning but preserves morphine reinforcement. Biol Psychiatry 69: 700-703.
33. Liu X, Jernigan C (2011). Activation of the opioid m1, but not d or k, receptors is required for nicotine reinforcement in a rat model of drug self-administration. Prog Neuropsychopharmacol Biol Psychiatry 35: 146-153.
34. Longoni R, Spina L, Mulas A, Carboni E, Garau L, Melchiorri P et al (1991). (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J Neurosci 11: 1565-1576.
35. Maisonneuve IM, Glick SD (1999). (+/-)Cyclazocine blocks the dopamine response to nicotine. Neuroreport 10: 693-696. (Pubitemid 29393807)
36. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E (1997). Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388: 586-589. (Pubitemid 27340008)
37. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1987). Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7: 2445-2464.
38. Mansvelder HD, McGehee DS (2002). Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 53: 606-617. (Pubitemid 35375590)
39. Martín-García E, Barbano MF, Galeote L, Maldonado R (2009). New operant model of nicotine-seeking behaviour in mice. Int J Neuropsychopharmacol 12: 343-356.
40. McCarthy MJ, Zhang H, Neff NH, Hadjiconstantinou M (2011). Desensitization of d-opioid receptors in nucleus accumbens during nicotine withdrawal. Psychopharmacology (Berl) 213: 735-744.
41. Molander C, Xu Q, Grant G (1984). The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J Comp Neurol 230: 133-141. (Pubitemid 15221509)
42. Olmstead MC, Ouagazzal AM, Kieffer BL (2009). Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS One 4: e4410.
43. Paxinos G, Franklin KBJ (1997). The Mouse Brain in Stereotaxic Coordinates. Academic: San Diego.
44. Plaza-Zabala A, Martín-García E, de Lecea L, Maldonado R, Berrendero F (2010). Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci 30: 2300-2310.
45. Pradhan AA, Clarke PB (2005). Comparison between delta-opioid receptor functional response and autoradiographic labeling in rat brain and spinal cord. J Comp Neurol 481: 416-426.
46. Pradhan AA, Befort K, Nozaki C, Gavériaux-Ruff C, Kieffer BL (2011). The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci 32: 581-590.
47. Roberts AJ, Gold LH, Polis I, McDonald JS, Filliol D, Kieffer BL et al (2001). Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res 25: 1249-1256. (Pubitemid 32868332)
48. Roth-Deri I, Green-Sadan T, Yadid G (2008). Beta-endorphin and drug-induced reward and reinforcement. Prog Neurobiol 86: 1-21.
49. Shippenberg TS, LeFevour A, Chefer VI (2008). Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. CNS Neurol Disord Drug Targets 7: 442-453.
50. Sim LJ, Selley DE, Childers SR (1995). In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate binding. Proc Natl Acad Sci USA 92: 7242-7246.
51. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A et al (1998). Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 17: 886-897. (Pubitemid 28077643)
52. Soria G, Mendizábal V, Touriño C, Robledo P, Ledent C, Parmentier M et al (2005). Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 30: 1670-1680. (Pubitemid 43086024)
53. Stevenson GW, Folk JE, Rice KC, Negus SS (2005). Interactions between delta and mu opioid agonists in assays of schedulecontrolled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5- dimethyl- 1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin. J Pharmacol Exp Ther 314: 221-231. (Pubitemid 41058259)
54. Suzuki T, Tsuji M, Ikeda H, Misawa M, Narita M, Tseng LF et al (1997). Antisense oligodeoxynucleotide to delta opioid receptors blocks cocaine-induced place preference in mice. Life Sci 60: 283-288.
55. Svingos AL, Clarke CL, Pickel VM (1998). Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin. J Neurosci 18: 1923-1933. (Pubitemid 28103100)
56. Tanda G, Di Chiara G (1998). A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and nonpsychostimulant drugs of abuse. Eur J Neurosci 10: 1179-1187. (Pubitemid 28375643)
57. Trigo JM, Zimmer A, Maldonado R (2009). Nicotine anxiogenic and rewarding effects are decreased in mice lacking betaendorphin. Neuropharmacology 56: 1147-1153.
58. Walsh Z, Epstein A, Munisamy G, King A (2008). The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation. J Addict Dis 27: 65-72.
59. Walters CL, Cleck JN, Kuo YC, Blendy JA (2005). Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron 46: 933-943. (Pubitemid 40805353)
60. Watkins SS, Stinus L, Koob GF, Markou A (2000). Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292: 1053-1064. (Pubitemid 30136601)